Muhamed Baljevic, MD

Assistant Professor

  • 1054 Citations
  • 6 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Muhamed Baljevic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences
Qatar Medicine & Life Sciences
Proteasome Inhibitors Medicine & Life Sciences
Compulsive Behavior Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Conflict of Interest Medicine & Life Sciences
Medical Ethics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 1054 Citations
  • 6 h-Index
  • 9 Article
  • 4 Review article

Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines

Kumar, S. K., Callander, N. S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., Castillo, J. J., Chandler, J. C., Cornell, R. F., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Holmberg, L., Htut, M., Huff, C. A., Kang, Y., Landgren, O., Malek, E. & 11 others, Martin, T., Omel, J., Raje, N., Sborov, D., Singhal, S., Stockerl-Goldstein, K., Tan, C., Weber, D., Johnson-Chilla, A., Keller, J. & Kumar, R., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 10, p. 1154-1165 12 p.

Research output: Contribution to journalReview article

Open Access
Multiple Myeloma
Guidelines
Aftercare
Paraproteinemias
Plasmacytoma

Pharmacodynamics and pharmacokinetics of proteasome inhibitors for the treatment of multiple myeloma

Baljevic, M. & Orlowski, R. Z., Jun 3 2019, In : Expert Opinion on Drug Metabolism and Toxicology. 15, 6, p. 459-473 15 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Proteasome Inhibitors
Pharmacokinetics
Multiple Myeloma
Proteasome Endopeptidase Complex
4 Citations (Scopus)

Present and future of immunotherapy in the management of multiple myeloma

Baljevic, M. & Holstein, S. A., Jul 1 2018, In : Journal of oncology practice. 14, 7, p. 403-410 8 p.

Research output: Contribution to journalReview article

Multiple Myeloma
Immunotherapy
Transplantation
Proteasome Inhibitors
Antigen Presentation
7 Citations (Scopus)

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

Baljevic, M., Zaman, S., Baladandayuthapani, V., Lin, Y. H., de Partovi, C. M., Berkova, Z., Amini, B., Thomas, S. K., Shah, J. J., Weber, D. M., Fu, M., Cleeland, C. S., Wang, X. S., Stellrecht, C. M., Davis, R. E., Gandhi, V. & Orlowski, R. Z., Jun 1 2017, In : Annals of Hematology. 96, 6, p. 977-985 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Disease Progression
Aptitude
Hepatocyte Growth Factor
ARQ 197
3 Citations (Scopus)

Telomere length recovery: A strong predictor of overall survival in acute promyelocytic leukemia

Baljevic, M., Dumitriu, B., Lee, J. W., Paietta, E. M., Wiernik, P. H., Racevskis, J., Chen, C., Stein, E. M., Gallagher, R. E., Rowe, J. M., Appelbaum, F. R., Powell, B. L., Larson, R. A., Coutré, S. E., Lancet, J., Litzow, M. R., Luger, S. M., Young, N. S. & Tallman, M. S., Nov 1 2016, In : Acta Haematologica. 136, 4, p. 210-218 9 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Telomere
Survival
Stem Cells
Genes